JEMVESTA 25MG14 Tablets

JEMVESTA

JEMVESTA 25MG14 Tablets

Empagliflozin

Wilshire Laboratories (Private) Limited pc 1 units

Drug Identity

Active Ingredient
Empagliflozin
Drug Class
Blood Glucose Lowering Drugs, Excluding Insulin
ATC Code
A10BK03
Status
Essential Medicine

What is JEMVESTA?

Uses
Empagliflozin is used together with diet and exercise to lower blood sugar levels in adults and children at least 10 years old with type ...

How to Take It

1
Adult
Scraped Dose
Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed. Take empa

Safety Alerts

Diabetic ketoacidosis, severe hepatic impairment, severe renal impairment
Elderly over 85 yrs age

Important Warnings

Congestive heart failure and cardiovascular disease, hepatic impairment, renal impairment, complicated urinary tract infections
consider temporarily interrupting treatment
Avoid initiation if eGFR below 60 ml/minute/1
Avoid if eGFR is persistently below 45 ml/minute/1
Monitor renal function before starting treatment and regularly during treatment
Monitor electrolyte balance and ensure adequate hydration
Correct hypovolaemia before starting treatment
Consider interrupting treatment if volume depletion occurs, concomitant antihypertensive therapy or use of diuretics

Side Effects

Genital infectionhypoglycaemia (in combination with insulin or sulfonylurea)polyuriapruritusurinary tract infectiondysuriavolume depletion (rare)

Drug Interactions

Diuretics
antihypertensive
UGT enzyme inducers
agents affecting renal functions

Pregnancy & Lactation

Pregnancy
Advised to avoid
Lactation
Advised to avoid

Price Intelligence

Rs 29.45
DVAGO observed price · as of 30 July 2026
Rs 29.45 per unit
DRAP approved ceiling: Rs 978.36 (per pack of 14)
Rs 29.45 per unit observed vs Rs 69.88 per unit approved — but the two are quoted for different pack sizes (retail pack vs per pack of 14), and DRAP sets a separate ceiling per pack size. Indicative only; not a compliance finding.
Reg. 107163 · approved 25 Aug, 2025
Prices across sources
DVAGORs 29.45
DRAPper pack of 14Rs 978.36

Should you consider an alternative?

Other options containing Empagliflozin, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.